HNRNPA2B1 and glioblastoma: HNRNPA2/B1 down-regulating inhibits p-STAT3 and MMP-2 levels and reduces GBM cell viability, adhesion, migration, invasion, and chemoresistance for TMZ capacity (Deng et al., 2016).